Jason I Kass1, Steve C Lee2, Shira Abberbock3, Raja R Seethala4, Umamaheswar Duvvuri5. 1. Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 2. Department of Otolaryngology, Loma Linda Medical Center, Loma Linda, California, U.S.A. 3. Department of Biostatistics, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. 4. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 5. Department of Otolaryngology, VA Pittsburgh Health System, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Abstract
OBJECTIVES/HYPOTHESIS: Adenosquamous carcinoma (ASC) is a rare variant of head-and-neck squamous cell carcinoma (HNSCC) generally thought to be uniformly aggressive with poor prognosis. However, it remains unknown how overall survival compare with conventional HNSCC. Here we report for the first time that ASC does not necessarily indicate a worse prognosis than conventional HNSCC. STUDY DESIGN: Case-control retrospective study. METHODS: Forty-two primary tumors of the head and neck, treated with curative intent, were identified. Next, 2:1 matching of HNSCC was performed using the following matching criteria: gender, site, pathologic tumor stage, and pathologic node stage. Successful matching was performed for 32 of 42 tumors. Additionally, 20 samples were sent for break-apart FISH testing to evaluate for the presence of the CRTC1-MAML2 translocation. RESULTS: There was a 1.8:1 male to female ratio, with a mean age of 62 years (range 38-84). The layrnx was the most common site (26%), followed by oropharynx (24%), oral cavity (19%), and sinonasal (17%). Kaplan-Meier analysis of adenosquamous and matched HNSCC showed similar survival curves. Median survival times for ASC and HNSCC were 4 and 6 years, respectively. A random-effects Cox model with Gamma frailty revealed no statistical difference between the two groups (P=0.25). All cases of ASC were negative for the CRTC1-MAML2 translocation. CONCLUSION: This study directly compares primary ASC with HNSCC. No difference in overall survival was detected in contradistinction to the previously thought uniformly poor prognosis. We also highlight the importance of the CRTC1-MAML2 translocation in distinguishing ASC from mucoepidermoid carcinoma. LEVEL OF EVIDENCE: 3b.
OBJECTIVES/HYPOTHESIS: Adenosquamous carcinoma (ASC) is a rare variant of head-and-neck squamous cell carcinoma (HNSCC) generally thought to be uniformly aggressive with poor prognosis. However, it remains unknown how overall survival compare with conventional HNSCC. Here we report for the first time that ASC does not necessarily indicate a worse prognosis than conventional HNSCC. STUDY DESIGN: Case-control retrospective study. METHODS: Forty-two primary tumors of the head and neck, treated with curative intent, were identified. Next, 2:1 matching of HNSCC was performed using the following matching criteria: gender, site, pathologic tumor stage, and pathologic node stage. Successful matching was performed for 32 of 42 tumors. Additionally, 20 samples were sent for break-apart FISH testing to evaluate for the presence of the CRTC1-MAML2 translocation. RESULTS: There was a 1.8:1 male to female ratio, with a mean age of 62 years (range 38-84). The layrnx was the most common site (26%), followed by oropharynx (24%), oral cavity (19%), and sinonasal (17%). Kaplan-Meier analysis of adenosquamous and matched HNSCC showed similar survival curves. Median survival times for ASC and HNSCC were 4 and 6 years, respectively. A random-effects Cox model with Gamma frailty revealed no statistical difference between the two groups (P=0.25). All cases of ASC were negative for the CRTC1-MAML2 translocation. CONCLUSION: This study directly compares primary ASC with HNSCC. No difference in overall survival was detected in contradistinction to the previously thought uniformly poor prognosis. We also highlight the importance of the CRTC1-MAML2 translocation in distinguishing ASC from mucoepidermoid carcinoma. LEVEL OF EVIDENCE: 3b.
Authors: Hardeep S Mudhar; Tatyana Milman; Paul J L Zhang; Carol L Shields; Ralph C Eagle; Sara E Lally; Jerry A Shields; Sachin M Salvi; Paul A Rundle; Jennifer Tan; Ian G Rennie Journal: Mod Pathol Date: 2020-01-13 Impact factor: 7.842
Authors: Julia C Thierauf; Alex A Farahani; B Iciar Indave; Adam Z Bard; Valerie A White; Cameron R Smith; Hetal Marble; Martin D Hyrcza; John K C Chan; Justin Bishop; Qiuying Shi; Kim Ely; Abbas Agaimy; Maria Martinez-Lage; Vania Nose; Miguel Rivera; Valentina Nardi; Dora Dias-Santagata; Salil Garg; Peter Sadow; Long P Le; William Faquin; Lauren L Ritterhouse; Ian A Cree; A John Iafrate; Jochen K Lennerz Journal: Int J Mol Sci Date: 2022-04-13 Impact factor: 6.208
Authors: Valerie A White; Martin D Hyrcza; Jochen K Lennerz; Julia Thierauf; Dilani Lokuhetty; Ian A Cree; Blanca Iciar Indave Journal: Mod Pathol Date: 2022-07-23 Impact factor: 8.209